Abstract Details

Title Film as a Health Communication Tool in Hispanics to Understand Perceptions and Attitudes in Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) P11 - Poster Session 11 (8:00 AM-9:00 AM)

Poster/Presentation
Number 9-015

Objective

To address if a pre-produced short-film can change illness perceptions and promote self-efficacy in multiple sclerosis.

Background Accurate illness perceptions are important in the self-management of MS and sociocultural perceptions are a concern in Hispanics affected with MS. To address this, we developed a short-film health intervention to examine illness perceptions and self-efficacy. The short film has been previewed at a National Center for Advancing Translational Sciences conference, and national and international conferences in MS and rehabilitation.

Design/Methods

Prospective, longitudinal mixed method study (quantitative + qualitative), of self-identified Hispanics diagnosed with MS in US mainland and Puerto Rico. Participants were assigned to view the short film intervention or not at baseline and then interviewed at 1 and 3 month follow-ups. At 6 months, participants were randomly invited to be part of 1 of 3 focus group sessions to further explore attitudes. The Brief Illness Perception (BIP) and MS Self-Efficacy (MSSE) questionnaire were taken at each time point. A change in the overall scores and individual domains were evaluated with analysis of variance. Multivariate linear regression was used to examine predictors of change.

Results In total, 200 participants completed the study. Mean BIP scores at 3 months deviated between those who watched the film and those who did not with greater personal control (p=0.10) and MS concern (p=0.05). Greater MSSE scores in self-control (p=0.05) and function (p<0.01) were reported earlier (1 month) for those who watched the film. The best predictors of perceptions changing at 3 months were watching the film (Beta 5.83; p=0.02) and educational attainment (Beta -5.17; p<0.01). Focus group results were consistent in supporting that attitudes are driven by perceptions, culture, and available support networks.

Conclusions

Our results provide support that film is an acceptable means to address illness perceptions, explore attitudes, and promote self-efficacy in MS.

Authors/Disclosures
Lilyana M. Amezcua, MD, F�鶹��ýӳ�� (USC) PRESENTER	Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD serono. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Amezcua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. The institution of Dr. Amezcua has received research support from National MS Society. The institution of Dr. Amezcua has received research support from Genentech. The institution of Dr. Amezcua has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Amezcua has received research support from NIH NINDS. The institution of Dr. Amezcua has received research support from Sanofi/Genzyme. The institution of Dr. Amezcua has received research support from Alexion.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Michael V. Robers, MD (Barrow Neurological Institute)	Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation.
Ivonne Vicente, MD	Dr. Vicente has nothing to disclose.
Margaret E. Burnett, MD (University of Southern California, Keck School of Medicine)	Dr. Burnett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prism. Dr. Burnett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. Dr. Burnett has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Burnett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Burnett has received research support from Genentech.
Angel R. Chinea, MD	Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for novartis. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biogen. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for emd serono. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for genentech. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for emd serono. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Chinea has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for allergan.
Jacob L. McCauley (University of Miami)	No disclosure on file

�鶹��ýӳ��

�鶹��ýӳ��